Syndax Pharmaceuticals (SNDX) Gross Margin (2024 - 2026)
Syndax Pharmaceuticals (SNDX) reported Gross Margin of 83.20% for Q3 2026, down 12.22 percentage points from 95.42% a year earlier and down 12.40 percentage points from the prior quarter.
Powered by 
Analysis
Syndax Pharmaceuticals (SNDX) Gross Margin (2024 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Syndax Pharmaceuticals' Gross Margin came in at 92.22%, down 3.22 percentage points year-over-year; for FY2025, it was 95.96%, down 0.56 percentage points from FY2024.
- By year, Gross Margin came in at 96.51% in FY2024.
- The Q3 2026 figure ranks as the lowest quarterly Gross Margin in data going back to Q2 2024.
- Year over year, Gross Margin gained in two of the last six quarters, with an average year-over-year change of -2.34 percentage points.
- Per Business Quant data, the three quarters before Q3 2026 came in at 95.59% (Q2 2026), 95.94% (Q1 2026) and 96.06% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 83.88% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 75.38% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 72.95% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 78.02% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 83.60% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 73.10% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 81.07% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 75.71% |
| 10 | Syndax Pharmaceuticals | 871.86 Mn | -849.24 Mn | 69.30 Mn | 83.20% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 83.20% |
| Jun 30, 2026 | 95.59% |
| Mar 31, 2026 | 95.94% |
| Dec 31, 2025 | 96.06% |
| Sep 30, 2025 | 95.42% |
| Jun 30, 2025 | 96.63% |
| Mar 31, 2025 | 95.58% |
| Dec 31, 2024 | 89.24% |
| Sep 30, 2024 | 100.00% |
| Jun 30, 2024 | 100.00% |
API Access
Syndax Pharmaceuticals Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=SNDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "SNDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=SNDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();